These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38402132)
1. Urological Outcomes in Post-Pubertal Patients With Myelomeningocele: A Single-Center Retrospective Study. Pakkasjärvi N; Antila S; Mäkelä E; Taskinen S J Pediatr Surg; 2024 Jun; 59(6):1177-1181. PubMed ID: 38402132 [TBL] [Abstract][Full Text] [Related]
2. The urological fate of young adults with myelomeningocele: a three decade follow-up study. Peeker R; Damber JE; Hjälmås K; Sjödin JG; von Zweigbergk M Eur Urol; 1997; 32(2):213-7. PubMed ID: 9286656 [TBL] [Abstract][Full Text] [Related]
3. Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele. Smith MC; Strine AC; DeFoor WR; Minevich E; Noh P; Sheldon CA; Reddy PP; VanderBrink BA J Pediatr Urol; 2020 Feb; 16(1):32.e1-32.e8. PubMed ID: 31839471 [TBL] [Abstract][Full Text] [Related]
4. Urinary continence appears to enhance social participation and intimate relations in adolescents with myelomeningocele. Vu Minh Arnell M; Abrahamsson K J Pediatr Urol; 2019 Feb; 15(1):33.e1-33.e6. PubMed ID: 30228091 [TBL] [Abstract][Full Text] [Related]
5. Urinary and Fecal Continence in 5-Year-Old Patients Who Underwent in utero Myelomeningocele Repair: A Prospective Study. Macedo A; Cavalheiro S; Moron A; Lobountchenko T; Dini FS; Ottoni SL; Garrone G; Ligori R; Leal da Cruz M Fetal Diagn Ther; 2019; 46(5):319-322. PubMed ID: 30884481 [TBL] [Abstract][Full Text] [Related]
6. Association between age of starting clean intermittent catheterization and current urinary continence in individuals with myelomeningocele. Freeman KA; Liu T; Smith K; Castillo H; Castillo J; Joseph D; Wang Y; Tanaka S J Pediatr Urol; 2022 Oct; 18(5):614.e1-614.e10. PubMed ID: 36163222 [TBL] [Abstract][Full Text] [Related]
7. Continence outcomes following a modification of the Mitchell bladder neck reconstruction in myelomeningocele: A single institution experience. Malhotra NR; Wallis MC; Allen CM; Cartwright PC; Lau GA J Pediatr Urol; 2020 Oct; 16(5):653.e1-653.e8. PubMed ID: 32739361 [TBL] [Abstract][Full Text] [Related]
8. Lipomyelomeningocele for the urologist: Should we view it the same as myelomeningocele? Yerkes EB; Halline C; Yoshiba G; Meyer TA; Rosoklija I; Bowman R; McLone D; Cheng EY J Pediatr Urol; 2017 Aug; 13(4):371.e1-371.e8. PubMed ID: 28583853 [TBL] [Abstract][Full Text] [Related]
9. Urological consequences of incomplete cord lesions in patients with myelomeningocele. Keshtgar AS; Rickwood AM Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763 [TBL] [Abstract][Full Text] [Related]
10. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty. Corona LE; Lee T; Marchetti K; S Streur C; Ivancic V; Kraft KH; Bloom DA; Wan J; Park JM J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462 [TBL] [Abstract][Full Text] [Related]
11. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Vainrib M; Reyblat P; Ginsberg DA Neurourol Urodyn; 2013 Mar; 32(3):250-3. PubMed ID: 22965686 [TBL] [Abstract][Full Text] [Related]
12. Long-term urological and gynecological outcomes following complete primary repair in females with bladder exstrophy. Canalichio KL; Ahn J; Hwang C; Amies AM; Merguerian P; Shnorhavorian M J Pediatr Urol; 2021 Oct; 17(5):608.e1-608.e8. PubMed ID: 34391690 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele. Yu WR; Kuo HC Int Urol Nephrol; 2022 Aug; 54(8):1815-1824. PubMed ID: 35608803 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele. Kessler TM; Lackner J; Kiss G; Rehder P; Madersbacher H Neurourol Urodyn; 2006; 25(4):361-7. PubMed ID: 16721816 [TBL] [Abstract][Full Text] [Related]
15. Onabotulinumtoxin A for treating overactive/poor compliant bladders in children and adolescents with neurogenic bladder secondary to myelomeningocele. Marte A Toxins (Basel); 2012 Dec; 5(1):16-24. PubMed ID: 23274271 [TBL] [Abstract][Full Text] [Related]
16. Contemporary management and outcome of myelomeningocele: the Rotterdam experience. Spoor JKH; Gadjradj PS; Eggink AJ; DeKoninck PLJ; Lutters B; Scheepe JR; van Meeteren J; de Laat PCJ; van Veelen ML; de Jong THR Neurosurg Focus; 2019 Oct; 47(4):E3. PubMed ID: 31574477 [TBL] [Abstract][Full Text] [Related]
17. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood. Snow-Lisy DC; Yerkes EB; Cheng EY J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383 [TBL] [Abstract][Full Text] [Related]
18. Predictors of urinary continence following tethered cord release in children with occult spinal dysraphism. Frainey BT; Yerkes EB; Menon VS; Gong EM; Meyer TA; Bowman RM; McLone DG; Cheng EY J Pediatr Urol; 2014 Aug; 10(4):627-33. PubMed ID: 25067798 [TBL] [Abstract][Full Text] [Related]
19. Bladder Neck Surgery is not Routinely Needed to Achieve Urinary Continence in Patients with Primary Epispadias. Mariotto A; Keene DJ; Alshafei AR; Powell J; Cserni T; Cervellione RM J Pediatr Surg; 2024 Jun; 59(6):1182-1185. PubMed ID: 38195356 [TBL] [Abstract][Full Text] [Related]